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To test our hypothesis we first queried the information available in public 
databases on synaptic pathways (KEGG and GO databases) to obtain a list of 
606 genes involved in synaptic transmission. We intersected this gene list with 
the results of a large genomic screening for CNVs, carried out by the Autism 
Genome Project (AGP) in 1590 Caucasian ASD patients, and CNV information 
on the Database of Genomic Variants (DGV) to test if the frequency of CNVs 
encompassing synaptic genes is higher in the AGP population than in control 
subjects. Both cases and controls were matched for ancestry and CNV 
detection methodology (SNP arrays). Further, we use this gene list to identify 
genes in CNVs present exclusively on the AGP dataset, when comparing with 
the DGV and additional control datasets (Table 1). 
The present results confirm an excess of structural alterations encompassing 
synaptic genes in ASD and reaffirms the genetic complexity underlying ASD 
etiology. It highlights novel candidates for genomic sequencing and functional 
studies, as well as synapse-related pathways possibly compromised in this 
disorder. 
Copy Number Variants (CNVs) play an important role in susceptibility to ASD, 
often mediated by the deletion or duplication of genes involved in synaptic 
structure and function. Increasing evidence suggests a central role for defects 
in synaptic structure and function in the pathogenesis of non-syndromic ASD. 
In this study we tested the hypothesis of an enrichment in CNVs encompassing 
synaptic transmission genes in ASD. 
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Figure2.  Circus plot representing the CNVs deleting or duplicating genes involved in synaptic 
functions and exclusively identified in ASD probands. In a total of 206 CNVs, deletions (A) were shown 
to be more frequent (2:1 ratio, N=136 CNVs encompassing synaptic genes) than duplications (B) 
(N=70 CNVs encompassing synaptic genes). The type of structural variation per gene is represented by 
the color of the ribbon or ribbons (C) connected with gene specific segments (D) (blue for deletions 
and green for duplications). Genes are shown in a clockwise distribution, starting with those present in 
a higher number of CNVs. The purple star represents genes previously implicated in ASD etiology 
(according to information available in the AutismKB database on CNVs detected using SNPs 
microarrays, not present in control subjects and with Caucasian ancestry) that are also present in our 
dataset.  
CONCLUSION 
CONTROL DATASET 
NUMBER OF 
SAMPLES 
GENOTYPING PLATFORMS 
Database of Genomic Variants1,2,3,4 427 
Illumina HumanHap 300 BeadChip,  Illumina 
HumanHap 550 BeadChip,  Illumina Human  1M array,  
Affymetrix Genome Wide Human SNP array 6.0.  
The Children's Hospital of Philadelphia CNV project2 1320 Illumina HumanHap 550 BeadChip 
Study of Addiction: Genetics and Environment 
(SAGE)3 
1261 Illumina Human  1M array 
PopGene4 1123 Affymetrix Genome Wide Human SNP array 6.0  
Ottawa Heart Genomics Study4 1234 Affymetrix Genome Wide Human SNP array 6.0 
Total number of control samples 5365 -- 
Table1.  Control datasets.  
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 A total of 91 genes that were deleted and/or duplicated exclusively in the AGP dataset 
were identified. 
 
 Some of the synaptic genes identified in the ASD dataset CNVs have previously been 
described in ASD patients, like SHANK1, GABRA5, GABRG1 GRM5, GRIN3B, GRIK2, MBP, 
ERBB4 and PLCB1 (Figure 2).  
 
 However, novel genes not listed as ASD-candidate or implicated genes were also 
identified in this dataset:   
 
Novel genes: PLA2G4A, PPP3CB, GNG2, ADCY7, ADCY8, ADRBK1, ADRBK2, PPP2R3C, 
PPP3CB. 
 
Genes belonging to the same gene family of ASD candidate genes: SYN2 (Synapsin gene 
family); CHRNA4 (Superfamily of ligand-gated ion channels); PLCB3 (Phosphoinositide 
phospholipase C beta enzyme family). 
 
Genes implicated in other neuropsychiatric disorders: CHRNA4, SLC6A3, SYN2, DLG2. 
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 The intersection of the synaptic pathways gene list with AGP and DGV CNV 
data revealed a significantly increased burden of CNVs encompassing synaptic 
genes in ASD patients compared to controls (Fisher’s exact test P = 2.2x10-
16,OR=2.06).  
 
  45,2% of ASD cases present CNVs encompassing synaptic genes compared to 
30,7% of controls. Most ASD patients and controls had only one synaptic CNV 
per individual, however 12,8% of ASD cases presented more than one CNV 
encompassing synaptic genes, against 5,6% in controls. (Figure 1).  
 
 Closer inspection of the clinical history from a subset of 137 patients showed 
a co-occurrence of synaptic CNVs with brain morphology alterations in 5,1% of 
patients and neuropsychiatric conditions in relatives in 6,6%. For  example, in 
one male patient diagnosed with ASD and moderate intellectual disability (ID), 
deletions in  PLA2G4A, AKT3, PRKACB, HTR2B, CALY and a duplication of 
CACNA1F genes co-occurred with bilateral atrophy of the parietal brain region; 
another ASD patient  with moderate ID presented a deletion of the AKT3 and 
HCN1 genes associated with atrophy of the right region of the hippocampus and 
had a brother and father with schizophrenia; a female ASD patient with 
moderate ID with duplications encompassing the TH, HRAS, GNG13 and CAMK2B 
genes presented epilepsy and had a brother with ASD. 
Figure1. CNVs encompassing synaptic genes per individual.  
   
Table 2. Contingency table for burden calculation. 
AGP  DGV   
CNVs encompassing synaptic genes 1024 (2.95%) 193 (1.43%) 
CNVs not encompassing synaptic genes 34753 (97.05%) 13461 (98.57%) 
